Filtered By:
Condition: Congestive Heart Failure
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 1952 results found since Jan 2013.
Perioperative adverse cardiac events and mortality after non-cardiac surgery: a multicenter study
CONCLUSIONS: A nationwide multicenter study showed that PACE was significantly associated with increased one-year mortality. This association was stronger in high-risk surgery, older, male, and chronic kidney disease subgroups. Further studies to improve mortality associated with PACE are needed.PMID:37169362 | DOI:10.4097/kja.23043
Source: Korean Journal of Anesthesiology - May 11, 2023 Category: Anesthesiology Authors: Byungjin Choi Ah Ran Oh Jungchan Park Jong-Hwan Lee Kwangmo Yang Dong Yun Lee Sang Youl Rhee Sang-Soo Kang Seung Do Lee Sun Hack Lee Chang Won Jeong Bumhee Park Soobeen Seol Rae Woong Park Seunghwa Lee Source Type: research
Risk factors for post-discharge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities
Conclusions COVID-19 inpatients with cardiovascular disease experience high rates of ATE, VTE, or ACM through 90 days post-discharge. Age > 75 years, PAD, CAS, CHF, previous VTE, and ICU admission are independent risk factors.PMID:37146648 | DOI:10.1055/a-2087-3003
Source: Thrombosis and Haemostasis - May 5, 2023 Category: Hematology Authors: Dimitrios Giannis Mark Goldin Husneara Rahman Cristina P Sison Martin Lesser Sam Ngu James Tsang Michael Qiu Shreya Sanghani Jackson Yeh Miltiadis Matsagkas Eleni Arnaoutoglou Alex C Spyropoulos Source Type: research
Impact of direct oral anticoagulant concentration on clinical outcomes in Asian patients with atrial fibrillation
In conclusion, trough DOAC concentration measurements should be considered among patients at risk of out-of-expected range DOAC concentrations.PMID:37132484 | DOI:10.1002/cpt.2927
Source: Clinical Pharmacology and Therapeutics - May 3, 2023 Category: Drugs & Pharmacology Authors: Shin-Yi Lin Sung-Chun Tang Ching-Hua Kuo Li-Ting Ho Yen-Bin Liu Yu-Fong Peng Li-Kai Tsai Chih-Fen Huang Jiann-Shing Jeng Source Type: research
Po-05-141 association of interatrial block and the development of atrial fibrillation among patients with hypertrophic cardiomyopathy
Atrial fibrillation (AF) is the most common sustained arrhythmia among those with hypertrophic cardiomyopathy (HCM), affecting 1 in 5 patients. The combination of HCM and AF is associated with an increased risk of stroke, heart failure, and mortality. Interatrial block (IAB) is a distinct electrocardiographic (ECG) pattern describing conduction delay between the right and left atria through Bachmann ’s bundle. IAB has been identified as a predictor of AF across several disease states including congestive heart failure, valvular disease, and cardiac amyloidosis.
Source: Heart Rhythm - May 1, 2023 Category: Cardiology Authors: Abdullah Alissa, Nadia Bokhari, Munther K. Homoud, Ethan Rowin, Martin S. Maron, Christopher Madias Source Type: research
Pollution from fine particulate matter and atherosclerosis: A narrative review
Environ Int. 2023 Apr 10;175:107923. doi: 10.1016/j.envint.2023.107923. Online ahead of print.ABSTRACTAccording to the WHO, the entire global population is exposed to air pollution levels higher than recommended for health preservation. Air pollution is a complex mixture of nano- to micro-sized particles and gaseous components that poses a major global threat to public health. Among the most important air pollutants, causal associations have been established between particulate matter (PM), mainly < 2.5 μm, and cardiovascular diseases (CVD), i.e., hypertension, coronary artery disease, ischemic stroke, congestive heart...
Source: Atherosclerosis - April 29, 2023 Category: Cardiology Authors: Chiara Macchi Cesare R Sirtori Alberto Corsini Pier Mannuccio Mannucci Massimiliano Ruscica Source Type: research
People with severe obesity and a genetic pathway variant have increased risk of hypertension, Mayo Clinic research finds
ROCHESTER, Minn. — Obesity and its associated cardiometabolic issues are a major health concern in the U.S. and internationally. According to a study published in 2017, 12% of the world's adult population was affected by obesity in 2016, double the percentage from 30 years earlier. With obesity comes an increasing risk of cardiovascular disease, including stroke, congestive heart failure and myocardial infarction. Fortunately, obesity is a multifactorial disease that results from an energy balance dysregulation…
Source: News from Mayo Clinic - April 18, 2023 Category: Databases & Libraries Source Type: news
Comparison of thromboembolic risk scores for evaluating in-hospital events of COVID-19 patients
Conclusion: We showed that m-R2CHA2DS2-VASc and m-ATRIA-HSV scores were better than the rest in predicting mortality among COVID-19 patients.PMID:37038968 | DOI:10.2217/bmm-2022-0546
Source: Future Medicine: Biomarkers in Medicine - April 11, 2023 Category: Internal Medicine Authors: Ömer Genç Abdullah Yildirim M ürşide Genç Fahri Er G ökhan Alici Alaa Quisi Hazar Harbalio ğlu Samir Allahverdiyev İbrahim H Kurt Source Type: research
ERLEADA ® (apalutamide), First-and-Only Next-Generation Androgen Receptor Inhibitor with Once-Daily, Single-Tablet Option, Now Available in the U.S.
HORSHAM, Pa., April 3, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the availability of an additional tablet strength of ERLEADA® (apalutamide) in the United States. The introduction of the 240mg tablet provides the first-and-only option for a once-daily, single-tablet Androgen Receptor Inhibitor (ARI) approved for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).With two strengths available, healthcare professionals will have the flexibility to...
Source: Johnson and Johnson - April 3, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Association of non-HDL-C-to-HDL-C ratio with coronary lesions and its prognostic performance in first-onset NSTEMI
Conclusion: NON-HDL-C:HDL-C is associated with coronary lesions and prognosis in non-ST-segment elevation acute myocardial infarction.PMID:36994674 | DOI:10.2217/bmm-2022-0548
Source: Atherosclerosis - March 30, 2023 Category: Cardiology Authors: Qi Mao Jianhua Zhao Xiaohui Zhao Source Type: research
